Skip to content

O2matic Cardiology Protocol

Automatic Oxygen Supply With the O2matic Device for the Treatment of Hospitalized Heart Patients With Hypoxia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05452863
Acronym
O2matic-Card
Enrollment
60
Registered
2022-07-11
Start date
2022-03-01
Completion date
2024-03-18
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Diseases

Keywords

hypoxemia, cardiology, automatic oxygen supply

Brief summary

Automatic oxygen supply with the O2matic device has been shown to provided an enhanced oxygen treatment in patients with hypoxemia. O2matic was significantly better than manual control to maintain oxygen saturation within target interval and to reduce time with unintended hypoxemia in patients suffering from chronic obstructive pulmonary disease. This trial investigates the effect of using O2matic in hypoxic patients submitted to the Department of Cardiology.

Detailed description

Oxygen supply to patients with cardiovascular disease has been subject to several investigations. Both too much and too little oxygen is supposed to be harmful. The O2matic device is a new way of supplying oxygen treatment which is significantly better than manual control to maintain oxygen saturation within target interval and to reduce time with unintended hypoxemia. The device has past favorable tests in patients suffering from chronic obstructive pulmonary disease. This study investigates the application of the O2matic device on hypoxic patients admitted to the Cardiology ward.

Interventions

DEVICEO2matic administered oxygen

Oxygen supply is adjusted from an almost continuous measurement of the oxygen saturation with an appropriate an previously tested algorithm.

DEVICEManual oxygen supply and adjustments

Oxygen supply is adjusted from manual measurements of the oxygen saturation

Sponsors

Hvidovre University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized, open-label study

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with heart disease and an oxygen saturation below 94% admitted to the Department of Cardiology * Age of 30 or more * Intellectual capacity to participate in the trial * Willing to give informed accept of participation in the trial.

Exclusion criteria

* Unstable patients * Need for ventilatory support except intermittent continuous positive airway pressure * Fertile women (age\<55 years) with a positive pregnancy test * Unable to participate due to language or cognitive problems

Design outcomes

Primary

MeasureTime frameDescription
Time in designated saturation interval24 hours of treatmentWe have predefined an optimum saturation interval of 92-96% with a target of 93%

Secondary

MeasureTime frameDescription
Time with hypoxemia24 hours of treatmentTime with saturation below 92% but above 85%
Time with severe hypoxemia24 hours of treatmentTime with saturation below 85%
Time with hyperoxemia24 hours of treatmentTime with saturation above 96%

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026